Donald School Journal of Ultrasound in Obstetrics and Gynecology

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  18 (2024)
Volume  17 (2023)
Volume  16 (2022)
Volume  15 (2021)
Volume  14 (2020)
Volume  13 (2019)
Volume  12 (2018)
Volume  11 (2017)
Volume  10 (2016)
Volume  9 (2015)
Volume  8 (2014)
Volume  7 (2013)
Volume  6 (2012)
Volume  5 (2011)
Volume  4 (2010)
Volume  3 (2009)
Volume  2 (2008)
Volume  1 (2007)
Related articles

VOLUME 8 , ISSUE 2 ( April-June, 2014 ) > List of Articles

REVIEW ARTICLE

Role of Ultrasound in the Assessment of Female Infertility

Maria Sheikh

Keywords : Female infertility,Transvaginal ultrasound,Color Doppler,Polycystic ovary syndrome,Luteinized unruptured follicle syndrome,Luteal phase defect,Premature ovarian failure,Ovarian endometrioma,Pelvic inflammatory disease,Intrauterine adhesions,Septate uterus,Submucosal fibroid,Endometrial polyp

Citation Information : Sheikh M. Role of Ultrasound in the Assessment of Female Infertility. Donald School J Ultrasound Obstet Gynecol 2014; 8 (2):184-200.

DOI: 10.5005/jp-journals-10009-1354

License: CC BY-NC 4.0

Published Online: 01-03-2015

Copyright Statement:  Copyright © 2014; The Author(s).


Abstract

How to cite this article

Sheikh M, Kupesic Plavsic S. Role of Ultrasound in the Assessment of Female Infertility. Donald School J Ultrasound Obstet Gynecol 2014;8(2):184-200.

PDF Share
  1. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004;19(1):41.
  2. The role of color Doppler imaging in the diagnosis of polycystic ovary syndrome Am J Obstet Gynecol 1995;172(1):108-113.
  3. Ultrasound assessment of ovarian stroma hypertrophy in hyperandrogenism and ovulation disorders: visual analysis versus computerized quantification. Fertil Steril 1995;64(2):307-312.
  4. Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. Br Med J (Clin Res Ed) 1986;293(6543):355-359.
  5. The prevalence of polycystic ovaries in women with type 2 diabetes mellitus. Clin Endocrinol (Oxf) 2000;52(1):82-86.
  6. The prevalence of polycystic ovaries in patients with congenital adrenal hyperplasia and their close relatives. Clin Endocrinol (Oxf) 1990;33(4): 501-510.
  7. Nonclassic 21-hydroxylase deficiency. Fertil Steril 2006;86Suppl 1:S2.
  8. Identification of virilizing adrenal tumors in hirsute women. N Engl J Med 1994;331:968-973.
  9. Glucose intolerance in polycystic ovary syndrome: a position statement of the Androgen Excess Society. J Clin Endocrinol Metab 2007;92(12): 4546-4556.
  10. The pathophysiology of ovarian hyperstimulation syndrome: views and ideas. Hum Reprod 1997;12(6):1129-1137.
  11. The pathogenesis of the ovarian hyperstimulation syndrome. N Engl J Med 2003;349(8):729-732.
  12. Color Doppler and three-dimensional ultrasound imaging in infertility. Color Doppler, 3D and 4D ultrasound in gynecology, infertility and obstetrics. 2nd ed. New Delhi: Jaypee Brothers, 2011, p. 115-130.
  13. The accuracy of transvaginal ultrasonography in the diagnosis of endometrial abnormalities. Obstet Gynecol 1996;87(3):345-349.
  14. Hormonal contraception and risk of endometrial cancer: a systematic review. Endocr Relat Cancer 2010;17(4):R263-271.
  15. Emotional distress is a common risk in women with polycystic ovary syndrome: a systematic review and meta-analysis of 28 studies. Hum Reprod Update 2012;18(6):638-651.
  16. Luteinized unruptured follicle syndrome increased by inactive disease and selective cyclooxygenase 2 inhibitors in women with inflammatory arthropathies. Arthritis Care & Research 2011;63(9):1334-1338.
  17. The assessment of normal and abnormal luteal function by transvaginal color doppler sonography. Eur J Obstet Gynecol and Reprod Bio 1997;72(1):83-87.
  18. Changes in blood-flow impedance of the human corpus luteum throughout the luteal phase and during early pregnancy. Fertil Steril 2008;90(6):2334-2339.
  19. Ovarian stromal blood flow in women with polycystic ovaries: a possible new marker for diagnosis? Hum Reprod 1995;10(8):1992-1996.
  20. Comparison of various therapies for the luteinized unruptured follicle syndrome. Int J Fertil 1992;37(1):33-40.
  21. Luteal phase defect: comparison between Doppler velocimetry, histological and hormonal markers. Ultrasound Obstet Gynaecol 1997;9(2):105-112.
  22. Prognostic significance of morphologic changes of the corpus luteum by transvaginal ultrasound in early pregnancy monitoring. Obstet Gynecol 1995;85(1):37-41.
  23. Color flow pulsed Doppler ultrasound in diagnosing luteal phase defect. Fertil Steril 1995;64:500-504.
  24. A comparison of endometrial and subendometrial vascularity assessed by three-dimensional ultrasonography and power doppler angiography between healthy fertile women and women with unexplained primary recurrent miscarriage. Fertil Steril 2011;95(3): 1127-1129.
  25. Treatment of luteal phase defects in assisted reproduction. Curr Drug Targets 2013;14(8):832-842.
  26. Luteal phase support for in vitro fertilization-embryo-transfer-present and future methods to improve successful implantation. Clin Exp Obstet Gynecol 2012;39(4):422-428.
  27. Clinical practice. Primary ovarian insufficiency. N Engl J Med 2009;360(6):606-614.
  28. Premature ovarian failure. Orphanet J Rare Dis 2006;1(9):1750-1772.
  29. Primary and secondary amenorrhea. In: comprehensive gynecology, 3rd ed, Mosby, St. Louis 1997. p. 1043.
  30. Clinical sonographic pearls. In: Kupesic S, editor. Color Doppler, 3D and 4D ultrasound in gynecology, infertility and obstetrics. 2nd ed. New Delhi: Jaypee Brothers Medical Publishers Pvt Ltd. 2011, p. 270-272.
  31. A prospective evaluation of antral follicle function in women with 46,XX spontaneous primary ovarian insufficiency. Fertil Steril 2010;94(5):1769-1774.
  32. A syndrome characterized by primary ovarian insufficiency and decreased stature: report of 11 cases with a digression on hormonal control of axillary and pubic hair. Am J Med Sci 1942;204:625-648.
  33. Genes and translocations involved in POF. Am J Med Genet 2002;111(3):328-333.
  34. Influence of intermediate and uninterrupted FMR1 CGG expansions in premature ovarian failure manifestation. Hum Reprod 2006;21(4):952-957.
  35. FMR1 repeat sizes in the gray zone and high end of the normal range are associated with premature ovarian failure. Hum Genet 2005;117(4):376-382.
  36. Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in the fragile-X syndrome. Am J Hum Genet 2000;66(1):6-15.
  37. Hypergonadotropic hypogonadism in female patients with galactosemia. N Engl J Med 1981;304(17):994-998.
  38. Heterozygosity for the classical galactosemia mutation does not affect ovarian reserve and menopausal age. Reprod Sci 2007;14(8):780-785.
  39. Mutations in eIF4ENIF1 are associated with primary ovarian insufficiency. J Clin Endocrinol Metab 2013;98(9):E1534-1539.
  40. Adrenal antibodies detect asymptomatic auto-immune adrenal insufficiency in young women with spontaneous premature ovarian failure. Hum Reprod 2002;17(8):2096-2100.
  41. Polyglandular autoimmune syndromes. Am J Med Sci 1985;290(2):77-88.
  42. Ovarian antibodies as detected by indirect immunofluorescence are unreliable in the diagnosis of autoimmune premature ovarian failure: a controlled evaluation. BMC Womens Health 2003; 3(1):2.
  43. The case against ovarian biopsy for the diagnosis of premature menopause. Br J Obstet Gynaecol 1994;101(2):96-98.
  44. Gonadal effects of cancer therapy in girls. Cancer 1985;55(10):2364-2372.
  45. Effects of childhood leukemia and chemotherapy on puberty and reproductive function in girls. N Engl J Med 1976;294(21):1143-1146.
  46. Normal pregnancy after curative multiagent chemotherapy for choriocarcinoma with brain metastases. Acta Obstet Gynecol Scand 1991;70(7-8):611-613.
  47. Return of fertility after autologous stem cell transplantation. Fertil Steril 2002;77(2):419-421.
  48. Radiosensitivity of mammalian oocytes with particular reference to the human female. Am J Obstet Gynecol 1971;110(5):746-761.
  49. The association of hysterectomy and menopause: a prospective cohort study. Br J Obstet Gynaecol 2005;112:956-962.
  50. Effect of early menopause on bone mineral density and fractures. Menopause 2007;14(3 pt 2):567-571.
  51. A dose-response study of hormone replacement in young hypogonadal women: effects on intima media thickness and metabolism. Clin Endocrinol (Oxf) 2007;66(4):557-564.
  52. Premature ovarian failure is not premature menopause. Ann N Y Acad Sci 2000;900:393-402.
  53. Cumulative conception and live birth rates after oocyte donation: implications regarding endometrial receptivity. Hum Reprod 1997; 12(4):835-839.
  54. Treatment of autoimmune premature ovarian failure: case report. Human Reproduction 1999;14 (7):1777-1782.
  55. Resumption of ovarian function and pregnancies in 358 patients with premature ovarian failure. J Clin Endocrinol Metab 2011;96(12):3864-3872.
  56. The endoscopic localization of endometrial implants in the ovarian chocolate cyst. Fertil Steril 1994;61(6):1034-1038.
  57. Postsurgical ovarian failure after laparoscopic excision of bilateral endometriomas. Am J Obstet Gynecol 2006;195(2):421-425.
  58. Impaired uterine artery flow associated with the presence of ovarian endometrioma: preliminary results of a prospective study. J Ovarian Res 2014; 7(1): 18-21.
  59. Serum CA-125 in preoperative patients at high risk for endometriosis. Obstet Gynecol 2002; 99(3):375-380.
  60. ‘Kissing ovaries’: a sonographic sign of moderate to severe endometriosis. Fertil Steril 2005;83(1): 143-147.
  61. Endovaginal ultrasonography in the diagnosis of adenomyosis uteri: identifying the predictive characteristics. BJOG: Int J Obstet Gynaecol 1995;10(6):471-474.
  62. Excisional surgery versus ablative surgery for ovarian endometriomata. Cochrane Database Syst Rev 2008;16(2):CD004992. Available at: http://www.ncbi.nlm.nih.gov/pubmed/18425908‥
  63. Long-term adjuvant therapy for the prevention of postoperative endometrioma recurrence: a systematic review and meta-analysis. Acta Obstet Gynecol Scand 2013;92(1):8-16.
  64. The effect of surgical treatment for endometrioma on in vitro fertilization outcomes: a systematic review and meta-analysis. Fertil Steril 2009;92(1):75-87.
  65. The effect of endometriosis on in vitro fertilisation outcome: a systematic review and meta-analysis. BJOG 2011;120(11): 1308-1320.
  66. Pelvic inflammatory disease. Obstet Gynecol 2010;116(2 Pt 1):419-428.
  67. The value of transvaginal color Doppler in the assessment of pelvic inflammatory disease. J Ultrasound Med Biol 1995;6:733-738.
  68. Loss of nerve fibers in the oviduct isthmus in women with hydrosalpinx. Acta Histochem 2013;115(6):609-615.
  69. Pregnancy rates after invitro fertilization in cases of tubal infertility with and without hydrosalpinx: a meta-analysis of published comparative studies. Hum Reprod 1999;14(5):1243-1249.
  70. Fertil Steril 2008;90(3):S67-68.
  71. Essure® for management of hydrosalpinx prior to in vitro fertilisation: a systematic review and pooled analysis. BJOG 2014;PMID:24393165. Available at: http://www.ncbi.nlm.nih.gov/pubmed/24393165
  72. Hydrosalpinx and infertility: what about conservative surgical management? Eur J Obstet Gynecol Reprod Biol 2011;159(1):122-126.
  73. Etiology of and therapeutic approach to synechia uteri. Eur J Obstet Gynecol Reprod Biol 1996;65(1):109-113.
  74. Predictive value of transvaginal sonography performed before routine diagnostic hysteroscopy for evaluation of infertility. Fertil Steril 2000;73:412.
  75. Asherman syndromeone century later. Fertil Steril 2008;11:759-779.
  76. Diagnostic accuracy of sonohysterography, transvaginal sonography, and hysterosalpingography in patients with uterine cavity diseases. Fertil Steril 2000;73(2):406-411.
  77. J Minim Invas Gynecol 2010;17(1):1-7.
  78. Ultrasound is the optimal choice for guidance in difficult hysteroscopy. Ultrasound Obstet Gynecol 2012;11:715-718.
  79. Preoperative sonographic measurement of endometrial pattern predicts outcome of surgical repair in patients with severe Asherman's syndrome. Fertil Steril 1995;63(2):410-413.
  80. Fertil Steril 1988;49(6):944-955.
  81. The obstetric outcome of in vitro fertilization and embryo transfer in women with congenital uterine malformation. Am J Obstet Gynecol 1996;175(1):85-89.
  82. Complete septate uterus with longitudinal vaginal septum. Fertil Steril 2006;85(3):700-705.
  83. The uterus. In: Clinical Gynecologic Endocrinology and Infertility, Lippincott Williams & Wilkins, Philadelphia 1999. p. 148.
  84. Hysterosalpingography. Fertil Steril 2005; 83(6):1595-1606.
  85. Diagnostic accuracy of sonohysterography, hysterosalpingography and diagnostic hysteroscopy in diagnosis of arcuate, septate and bicornuate uterus. J Obstet Gynaecol Res 2011;37(3):178-186.
  86. Two-and three-dimensional ultrasonography and sonohysterography versus hysteroscopy with laparoscopy in the differential diagnosis of septate, bicornuate, and arcuate uteri. J Minim Invasive Gynecol 2013;20(1):90-99.
  87. Clinical value of three-dimensional transvaginal sonography in diagnosis of septate uterus and prediction of adverse pregnancy outcome. Zhonghua Fu Chan Ke Za Zhi 2013;48(7):499-503.
  88. Hysteroscopic metroplasty for septate uterus. Obstet Gynecol Clin North Am 1995;22(3):473-489.
  89. Uterine myomas: management. Fertil Steril 2007;88(2):255-271.
  90. Fibroids and infertility: an updated systematic review of the evidence. Fertil Steril 2009;91(4):1215-1223.
  91. Comparison of hysterosonography and hysteroscopy for diagnosing perimenopausal bleeding. Clin Exp Obstet Gynecol 2013; 40(2):246-249.
  92. Color Doppler sonohysterography of endometrial polyps and submucosal fibroids. J Ultrasound Med 2003;22(6):601-614.
  93. The assessment of benign uterine tumor vascularization by transvaginal color Doppler. Ultrasound Med Biol 1992;18:645-649.
  94. The effect of uterine fibroids on embryo implantation. Semin Reprod Med 2007;25(6):483-489.
  95. Treatment of uterine fibroids: is surgery obsolete? N Engl J Med 2007;356(4):411-413.
  96. Outcomes from assisted reproductive technology. Obstet Gynecol 2006;107(1):183-200.
  97. Treatment of endometrial polyps: a systematic review. Acta Obstet Gynecol Scand 2010;89(8):992-1002.
  98. Diagnosis and management of endometrial polyps: a critical review of the literature. J Minim Invasive Gynecol 2011;18(5):569-581.
  99. Likelihood ratio of sonohysterographic findings for discriminating endometrial polyps from submucosal fibroids. J Ultrasound Med 2014;33(1): 22-25.
  100. Recurrent implantation failure: definition and management. Reprod Biomed Online 2014;28(1):14-38.
  101. Hysteroscopy for treating subfertility associated with suspected major uterine cavity abnormalities. Cochrane Database Syst Rev 2013;1:CD009461. Available at: http://www.ncbi.nlm.nih.gov/pubmed/23440838.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.